文献速递甲状腺与浅表介入US

评估热消融治疗≥2 cm良性甲状腺结节疗效的预测模型:一项多中心回顾性研究

A Prediction Model for Assessing the Efficacy of Thermal Ablation in Treating Benign Thyroid Nodules ≥ 2 cm: A Multi-Center Retrospective Study.
PubMed 文献 · Ultrasound Med Biol · 2024-07-31

该多中心回顾性研究纳入4个三级中心2018年5月至2022年7月接受超声引导热消融的962例患者共1011个≥2 cm良性甲状腺结节,以12个月随访体积缩小率>50%为治疗成功,952个(94.2%)结节达到治疗成功。多因素logistic回归筛选出性别、结节成分、钙化、体积、最大径为独立影响因素并建立预测方程,模型在训练集和验证集的AUC分别为0.908(95%CI:0.868-0.947)和0.850(95%CI:0.748-0.952)。

要点

  • ≥2 cm良性甲状腺结节热消融后12个月治疗成功(体积缩小率>50%)者占94.2%(952/1011)。
  • 性别、结节成分、钙化、体积、最大径是体积缩小率>50%的独立影响因素(均P<0.05)。
  • 预测模型训练集AUC 0.908(95%CI:0.868-0.947),验证集AUC 0.850(95%CI:0.748-0.952)。

核心结论

  • 成功建立临床预测模型,可在术前预测>2 cm良性甲状腺结节接受超声引导热消融的治疗成功情况,作者认为该模型有助于医师评估疗效并制定个体化预后方案。

研究设计与样本

  • 多中心回顾性研究,纳入4个三级中心2018年5月至2022年7月接受超声引导热消融的962例患者共1011个≥2 cm良性甲状腺结节,以12个月随访体积缩小率>50%为治疗成功、≤50%为非治疗成功,在训练集用多因素logistic回归筛选独立影响因素并建立预测模型,在验证集以AUC评价模型区分度。

诊断标准与关键数值

  • 治疗成功定义为热消融后12个月随访体积缩小率>50%,非治疗成功定义为体积缩小率≤50%;预测方程:p=1/1+Exp∑[8.113-2.720×(若以实性为主)-2.790×(若实性)-1.275×(若10 mL<体积≤30 mL)-1.743×(若体积>30 mL)-1.268×(若伴钙化)-2.859×(若最大径>3 cm)+1.143×(若女性)];模型区分度训练集AUC 0.908(95%CI:0.868-0.947)、验证集AUC 0.850(95%CI:0.748-0.952)。

临床应用与阅片要点

  • 作者认为该模型有助于医师评估≥2 cm良性甲状腺结节超声引导热消融的治疗效果并制定个体化预后方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate a prediction model utilizing clinical and ultrasound (US) data for preoperative assessment of efficacy following US-guided thermal ablation (TA) in patients with benign thyroid nodules (BTNs) ≥ 2 cm.

MATERIALS AND METHODS: We retrospectively assessed 962 patients with 1011 BTNs who underwent TA at four tertiary centers between May 2018 and July 2022. Ablation efficacy was categorized into therapeutic success (volume reduction rate [VRR] > 50%) and non-therapeutic success (VRR ≤ 50%). We identified independent factors influencing the ablation efficacy of BTNs ≥ 2 cm in the training set using multivariate logistic regression. On this basis, a prediction model was established. The performance of model was further evaluated by discrimination (area under the curve [AUC]) in the validation set.

RESULTS: Of the 1011 nodules included, 952 (94.2%) achieved therapeutic success at the 12-month follow-up after TA. Independent factors influencing VRR > 50% included sex, nodular composition, calcification, volume, and largest diameter (all p < 0.05). The prediction equation was established as follows: p = 1/1 + Exp∑[8.113 -2.720 × (if predominantly solid) -2.790 × (if solid) -1.275 × (if 10 mL < volume ≤ 30mL) -1.743 × (if volume > 30 mL) -1.268 × (if with calcification) -2.859 × (if largest diameter > 3 cm) +1.143 × (if female)]. This model showed great discrimination, with AUC of 0.908 (95% confidence interval [CI]: 0.868-0.947) and 0.850 (95% CI: 0.748-0.952) in the training and validation sets, respectively.

CONCLUSIONS: A clinical prediction model was successfully developed to preoperatively predict the therapeutic success of BTNs larger than 2 cm in size following US-guided TA. This model aids physicians in evaluating treatment efficacy and devising personalized prognostic plans.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Lu MY, Zhou Y, Bo XW, et al. A Prediction Model for Assessing the Efficacy of Thermal Ablation in Treating Benign Thyroid Nodules ≥ 2 cm: A Multi-Center Retrospective Study. Ultrasound Med Biol. 2024. PMID: 39085001. doi:10.1016/j.ultrasmedbio.2024.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。